Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2089572 | 1.00 | CYP1A2 (0.50) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL2089573 | 1.00 | CYP1A2 (0.50) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL13389065 | 0.85 | CHRM3 (0.48) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL18901727 | 0.83 | CHRM3 (0.47) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL6904216 | 0.83 | MAPT (0.59) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL17827512 | 0.82 | CES1 (0.50) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL29605173 | 0.82 | KMT2A (0.40) | CYP1A2CHRM3KMT2ACYP3A4KDM4E | |
| SCHEMBL11734223 | 0.81 | ATM (0.52) | MAPTHIF1AALDH1A1CYP3A4KDM4E | |
| SCHEMBL3381201 | 0.81 | KMT2A (0.45) | CYP1A2CHRM3KCNN4MAPTKMT2A | |
| SCHEMBL288100 | 0.81 | MAPT (0.45) | CYP1A2CHRM3KCNN4MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109106606-A | Topical composition comprising bimatoprost and the method for stimulating hair growth using it | 阿勒根公司 | 2019-01-01 | — | — | CN | claimed |
| CN-105263469-B | Topical compositions comprising bimatoprost and methods of stimulating hair growth therewith | 阿勒根公司 | 2018-11-02 | — | — | CN | claimed |
| CN-105263469-A | Topical compositions comprising bimatoprost and methods of stimulating hair growth therewith | ALLERGAN INC | 2016-01-20 | — | — | CN | claimed |
| US-8163698-B2 | Dolastatin 15 derivatives | ABBOTT GMBH & CO. KG (DE) | 2012-04-24 | — | — | US | claimed |
| US-20100099843-A1 | DOLASTATIN 15 DERIVATIVES | ABBOTT GMBH & CO. KG (DE) | 2010-04-22 | — | — | US | claimed |
| US-20250019377-A1 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2025-01-16 | — | — | US | disclosed |
| CN-109106606-A | Topical composition comprising bimatoprost and the method for stimulating hair growth using it | 阿勒根公司 | 2019-01-01 | — | — | CN | disclosed |
| CN-105263469-B | Topical compositions comprising bimatoprost and methods of stimulating hair growth therewith | 阿勒根公司 | 2018-11-02 | — | — | CN | disclosed |
| CN-108601815-A | Peptides and their use in hair treatment | 雅芳产品公司 | 2018-09-28 | — | — | CN | disclosed |
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | BRISTOL MYERS SQUIBB CO (US) | 2017-12-14 | — | — | US | disclosed |
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | BRISTOL MYERS SQUIBB CO (US) | 2017-12-14 | — | — | US | disclosed |
| CN-107427479-A | The system and method for anti-alopecia-stopping | 芙丽雅国际公司 | 2017-12-01 | — | — | CN | disclosed |
| US-20090202483-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2009-08-13 | — | — | US | disclosed |
| US-20060270606-A1 | Dolastatin 15 derivatives | ABBOTT GMBH & CO., KG (DE) | 2006-11-30 | — | — | US | disclosed |
| US-7084110-B2 | Anticarcinogenic agents for treating cancer; pentapeptides, hexapeptides, heptapeptides, oligopeptides | ABBOTT GMBH & CO., KG (DE) | 2006-08-01 | — | — | US | disclosed |
| EP-0991658-B1 | DOLASTATIN 15 DERIVATIVES | ABBOTT GMBH & CO KG (DE) | 2005-12-28 | — | — | EP | disclosed |
| US-6458765-B1 | POLYPEPTIDES AS ANTICANCER AGENTS AND AGAINST CELL PROLIFERATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-01 | — | — | US | disclosed |
| CN-1328601-A | Methods and systems for predicting protein function | SCRIPPS RESEARCH INST (US) | 2001-12-26 | — | — | CN | disclosed |
| US-6143721-A | FOR TREATING CANCER IN MAMMALS | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-07 | — | — | US | disclosed |
| EP-0386839-A2 | Tetrahydroquinoline derivatives useful for neurodegenerative disorders | MERCK SHARP & DOHME LTD. (GB) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170355689-A1 | HEPATITIS C VIRUS INHIBITOR | HAVCR2, LIPC, PYGL | CYP1A2 2057/4885CHRM3 4012/4885KCNN4 4880/4885 |
| US-20100099843-A1 | DOLASTATIN 15 DERIVATIVES | DDOST, DBI, DAO | CYP1A2 3272/4885CHRM3 4637/4885KCNN4 1836/4885 |
| US-20250019377-A1 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | CYP11B2, CYP21A2, CYP11B1 | CYP1A2 97/4885CHRM3 1574/4885KCNN4 1731/4885 |
| US-20090202483-A1 | Hepatitis C Virus Inhibitors | HAVCR2, PYGL, HCCS | CYP1A2 2139/4885CHRM3 3883/4885KCNN4 4880/4885 |
| US-20060270606-A1 | Dolastatin 15 derivatives | DDOST, DBI, DAO | CYP1A2 3272/4885CHRM3 4637/4885KCNN4 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.